Cemal Cingi, Nuray Bayar Muluk, İbrahim Çukurova, Rıza Dündar, Ustün Osma, Cengiz Bal, Alaattin Zirek, Ali Budak, Ali Seyed Resuli, Asif Selimoğlu, Aslı Elif Tanuğur Samancı, Ayşe Karaoğullarından, Begüm Yılmaz, Bengi Arslan, Bilal Sizer, Celalettin Cihan, Çiğdem Fırat Koca, Deniz Avcı, Doğukan Aydenizöz, Ethem Ünver, Elvin Alaskarov, Emrah Gülmez, Fatih Gündoğan, Gözde Günay, Hasan Çetiner, Hilal Güngör, İsmail Salcan, Mahmut Emre Gündoğan, Makbule Özlem Akbay, Mehmet Akdağ, Mehmet Erkan Kaplama, Mehmet Yaşar, Mehtap Koparal, Murat Kar, Mustafa Altıntaş, Mümtaz Taner Torun, Nazım Bozan, Neslihan Sarı, Nihat Susaman, Nurten Küçük, Osman Erdoğan, Osman Gül, Özlem Sancaklı, Pınar Kundi, Rezzan Okyay Budak, Sait Karaman, Soner Taşar, Songül Demir, Şeyda Belli, Tarık Yağcı, Taylan Bilici, Turgut Çelik, Yavuz Sultan Selim Yıldırım, Ali Timucin Atayoglu, Reşat Kubilay Irkan, Duygu Zorlu, Demet Can
Objectives: This study aimed to evaluate how Rhinapi nasal spray affects symptoms of allergic rhinitis. Methods: In this prospective, multicenter, observational study, 10,000 patients (comprising 5028 males and 4972 females) exhibiting symptoms of allergic rhinitis (namely, nasal discharge, sneezing, nasal itching, and nasal obstruction) from different centers in different regions of Turkey were enrolled in the study between March 2022 and March 2023. All the patients wanted to participate in the study and were administered Rhinapi one puff to each nostril three times a day, for a period of 3 weeks...
January 29, 2024: Ear, Nose, & Throat Journal